Archives
-
(S)-(+)-Methoprene: Causal JH Assay Design
2026-09-02
Discover how (S)-(+)-Methoprene can separate juvenile hormone receptor signaling from endogenous hormone biosynthesis. This article translates miRNA–mRNA findings into rigorous assay designs for developmental endocrinology, metamorphosis, and arthropod toxicology.
-
Dexamethasone: Genotype-Aware Assay Design
2026-09-02
Dexamethasone is a glucocorticoid anti-inflammatory research tool whose effects depend on cellular state, genotype, and endpoint selection. This guide combines DHAP mechanism with multiple myeloma cell-line genomics to improve model choice, controls, and interpretation across inflammation, stem-cell, lymphoblastic, and neuroinflammation assays.
-
Mdivi-1 and ECM–Mitochondria Signaling
2026-09-01
Mdivi-1 is a selective DRP1 inhibitor that connects mitochondrial fission, apoptosis, and stress adaptation. This article interprets its use through the newly defined ECM-to-mitochondria signaling axis, offering a context-aware framework for mitochondrial dynamics research.
-
5hmC in Rice Drought: A Translational Playbook
2026-09-01
5-hme-dCTP and 5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate provide a defined substrate for investigating DNA hydroxymethylation, polymerase behavior, and epigenetic assay performance. Building on a rice drought-response study, this article outlines how translational researchers can move from chemical controls to context-aware gene expression regulation studies and crop resilience research.
-
5-Methyl-CTP for Robust mRNA Synthesis
2026-08-31
5-Methyl-CTP helps researchers test whether cytidine methylation improves mRNA durability and protein output in controlled in vitro transcription workflows. Its value extends from gene-expression assays to delivery studies, including personalized vaccine platforms that require both high-quality RNA cargo and efficient cellular presentation.
-
LNP Surface Charge and V-ATPase Drive Delivery
2026-08-31
The reference study proposes that lipid nanoparticle (LNP) tropism is determined by a synergy between particle surface charge and the endo/lysosomal V-ATPase activity of target cells. Its in vitro and in vivo findings shift attention from nanoparticle design alone toward matching vector properties with the functional state of recipient tissues.
-
RCN2–UBR5–PPP2CA Axis in ESCC Resistance
2026-08-30
The reference study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent ubiquitination and degradation of PPP2CA, which activates PI3K-AKT signaling. Its multi-omics and biochemical validation strategy provides a framework for testing pathway-directed interventions while highlighting the need to distinguish direct evidence from broader PI3K/Akt/mTOR signaling hypotheses.
-
BKT140 (BL-8040): Translating CXCR4 Biology
2026-08-29
CXCR4 is more than a tumor marker: it is a control point for malignant-cell retention, survival, migration, and hematopoietic trafficking. This thought-leadership guide positions BKT140, also known as BL-8040 and TF 14016, as a research tool for connecting CXCR4 mechanism to functional assays, translational biomarkers, and precision oncology strategy.
-
TMRE Mitochondrial Membrane Potential Assay Guide
2026-08-28
Learn how the TMRE mitochondrial membrane potential assay kit converts ΔΨm changes into interpretable evidence of mitochondrial stress, apoptosis, and sodium-driven necrosis. This guide emphasizes causal assay design, controls, and the limitations that matter when translating fluorescence into mitochondrial function analysis.
-
Intestinal TM6SF2, the Gut–Liver Axis, and MASH
2026-08-28
A 2025 Nature Metabolism study shows that intestinal, rather than only hepatic, TM6SF2 deficiency can drive MASH through coordinated changes in fatty-acid handling, barrier integrity, microbiota, and lysophosphatidic acid signaling. The work provides a mechanistic gut–liver framework and identifies microbiota modulation and LPA-receptor blockade as testable intervention points.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Guide
2026-08-27
Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), SKU R1011, separates mRNA uptake from functional translation in viability, proliferation, cytotoxicity, and macrophage-delivery experiments. This scenario-based guide combines product specifications with evidence from macrophage nanoparticle research to improve assay interpretation and workflow consistency.
-
5-hme-dCTP in DNA Hydroxymethylation Assays
2026-08-27
Learn how 5-hme-dCTP supports controlled polymerase assays, positive controls, and workflow optimization for 5hmC research. The guide translates rice drought-epigenetics findings into practical choices for DNA hydroxymethylation assays without overstating what the nucleotide can prove on its own.
-
Dasatinib (BMS-354825) Research Workflows
2026-08-26
Build reproducible Src and Bcr-Abl signaling assays with Dasatinib (BMS-354825), from short-window phosphoprotein measurements to migration and metastasis studies. This guide connects validated prostate cancer and PDAC use cases with a hypothesis-driven framework for testing EMT and kinase crosstalk.
-
CD163+ Macrophages and Granulosa Cell Apoptosis in PCOS
2026-08-26
Ye et al. identify elevated CD163 expression in ovarian macrophages as a potential link between inflammatory remodeling and granulosa cell apoptosis in polycystic ovary syndrome. By combining transcriptomic analysis, patient serum measurements, a DHEA-induced mouse model, and macrophage-conditioned media experiments, the study provides a framework for investigating immune–follicular interactions in PCOS.
-
Bafilomycin C1: Reliable Lysosomal Assays
2026-08-25
Learn how Bafilomycin C1 (SKU C4729) can improve interpretation of autophagy, viability, and high-content cytotoxicity experiments through controlled V-ATPase inhibition. This scenario-based guide covers assay compatibility, handling, controls, data interpretation, and practical product-selection criteria.